---
type: "Symbol"
title: "Yili Chuanning Bio (301301.SZ) — 社區討論"
description: "該股票的社區討論，包括分析師觀點、財報解讀和投資策略，來自認證金融專業人士和活躍投資者。"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/301301.SZ/topics.md"
symbol: "301301.SZ"
parent: "https://longbridge.com/zh-HK/quote/301301.SZ.md"
count: 3
datetime: "2026-03-14T21:16:05.596Z"
locales:
  - [en](https://longbridge.com/en/quote/301301.SZ/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301301.SZ/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301301.SZ/topics.md)
---

# Yili Chuanning Bio (301301.SZ) — 社區討論

### [Annual net profit of 1.4 billion! SynbioTech, performance continues to "deliver"](https://longbridge.com/zh-HK/topics/29082758.md)

- 作者: [侃见财经](https://longbridge.com/zh-HK/profiles/3206955.md)
- 日期時間: 2025-04-23T02:16:58.000Z
- 評論: 0
- The bottom of the pharmaceutical industry has become clear, with many leading companies already showing signs of recovery. Coupled with the digestion of centralized procurement factors, the valuation 

### [Kelun Pharmaceutical made it ashore? The story of pharmaceutical company spin-offs is far from over.](https://longbridge.com/zh-HK/topics/21326556.md)

- 作者: [药械Talks](https://longbridge.com/zh-HK/profiles/6059509.md)
- 日期時間: 2024-05-23T11:00:19.000Z
- 評論: 0
- "Kelun has now successfully landed," this statement by Liu Gexin, chairman of Kelun Pharmaceutical, has sparked heated discussions in the industry and also unveiled the mystery behind spin-off

### [10 亿！抗生素中间体龙头「造血启示录」](https://longbridge.com/zh-HK/topics/11372370.md)

- 作者: [药械Talks](https://longbridge.com/zh-HK/profiles/6059509.md)
- 日期時間: 2024-01-28T03:07:06.000Z
- 評論: 0
- 辽阔的医药疆土上，一颗合成生物学新星正在冉冉升起。近日，$Yili Chuanning Bio(301301.SZ) 发布了 2023 年度业绩预告：实现归母净利润 9 亿元至 9.9 亿元，比上年同期增长 118.70% 至 140.57%，扣非净利润为 9 亿元至 9.9 亿元，同比增长 101.51% 至 121.66%，2023 年度业绩创下历史最好水平。如今的川宁生物，不仅在医药中间体领

## 參考連結

- [Yili Chuanning Bio (301301.SZ)](https://longbridge.com/zh-HK/quote/301301.SZ.md)


> 支持的語言: [English](https://longbridge.com/en/quote/301301.SZ/topics.md) | [简体中文](https://longbridge.com/zh-CN/quote/301301.SZ/topics.md)